| 69.30 Data as of May 17 |  +0.32 / +0.46%Today’s Change | 52.90 Today|||52-Week Range 75.78 | -1.34% Year-to-Date |
| Previous close | 68.98 |
| Today’s open | 69.43 |
| Day’s range | 68.10 - 69.48 |
| Volume | 666,962 |
| Average volume (3 months) | 815,380 |
| Market cap | $7.5B |
| Dividend yield | -- |
| Earnings growth (last year) | +11.90% |
| Earnings growth (this year) | +9.17% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | +8.04% |
| P/E ratio | 17.7 |
| Price/Sales | 2.39 |
| Price/Book | 5.02 |
| Today’s change | Today’s % change | |
|---|---|---|
| RMDResMed Inc | +0.27 | +0.54% |
| TFXTeleflex Inc | -0.18 | -0.22% |
| THORThoratec Corp | -0.63 | -1.90% |
| STJSt. Jude Medical Inc | +0.18 | +0.38% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $1.01 |
| Annual revenue (last year) | $2.8B |
| Annual profit (last year) | $427.0M |
| Net profit margin | 15.22% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Dow R. Wilson, MBA |
Chief Financial Officer & Executive Vice President Elisha W. Finney, MBA |
Corporate headquarters Palo Alto, California |
.
